ArticleCancer management and research2020

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor.

Jian-De Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.